Category: Start-ups

Lumedica's OCT

November 3, 2017

Duke Innovations Start-ups OCT for the People

[This article originally published on The Translational Scientist, November 2,...

Realtime Robotics Logo

July 20, 2018

Start-ups Realtime Robotics, Inc Awarded Competitive Grant from the National Science Foundation

[Originally posted by realtimerobotics — July 3, 2018] Small Business...

Startup Logo Phasebio

September 7, 2018

Duke Innovations Start-ups PhaseBio Secures $34 Million in Series D Financing

  “PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on...

Humacyte Phase II Vascular Trauma

October 30, 2018

Clinical Trials Start-ups Humacyte launches Phase II vascular trauma Humacyl vessel trial

Humacyte said yesterday it launched a U.S. Phase II trial of...

Innavasc President & CEO, Joe Knight, along with Senior Development Engineer, Craig Nichols and founder, Shawn Gage met with President Price to show him InnAVasc's puncture proof vascular graft. Photo by Jared Lazarus/Duke Photography

December 7, 2018

Biotechnology Start-ups Awards NCBiotech Awards $500K to InnAVasc

A $500,000 loan from the North Carolina Biotechnology Center will help...


March 4, 2019

Biotechnology Start-ups Off-the-shelf CAR-T and gene-editing player Precision Bio files $100M IPO

Precision BioSciences is looking to raise up to $100 million...

Rob Hallford at Duke Venture Day May 2019

May 9, 2019

Duke Innovations Start-ups Venture Capital Venture Day Showcased 8 Duke Start-ups in Biotech & Therapeutics

On Wednesday, May 1st, over a dozen venture capital firms...


July 19, 2019

Start-ups DMC Bio, Inc. Announces First Close of $10.3M Series A Financing Led by Sofinnova Partners

DMC, an early-stage biotechnology company, announced today that is has...

Duke Investor Day people gathering and chatting with each other

September 27, 2019

Featured Stories Start-ups Venture Capital Investing in the Future of Duke Technologies

On Tuesday, over 20 angel investor organizations, venture capitalists, and...


January 16, 2020

Biotechnology Start-ups Precision BioSciences Announces FDA Acceptance of IND for PBCAR269A, a BCMA Targeted Genome Edited Allogeneic CAR T Therapy

Precision BioSciences, Inc. (Nasdaq: DTIL), a genome editing company dedicated...